Mechanism: The circadian clock protein REV-ERBα recruits HDAC3 to the MLH1 promoter, deacetylating histones and maintaining DNA mismatch repair (MMR) capacity. Readout: Readout: Aging or circadian disruption reduces REV-ERBα and HDAC3 activity, leading to MLH1 silencing and lowered MMR efficiency, a process partially rescued by NR supplementation which improves MMR efficiency by 40%.
Hypothesis
The core circadian repressor REV-ERBα drives a daily wave of HDAC3 recruitment to the MLH1 promoter, promoting histone deacetylation and sustaining mismatch repair (MMR) capacity in colonic epithelial cells. With age, dampened REV-ERBα rhythm reduces HDAC3 occupancy, leading to promoter hyperacetylation, a repressive chromatin switch, and epigenetic silencing of MLH1. This mechanistic link explains how circadian erosion precipitates MMR decline, microsatellite instability, and early‑onset colorectal cancer (CRC).
Mechanistic Rationale
- REV-ERBα binds heme and recruits the NCOR1/HDAC3 corepressor complex in a ligand‑dependent manner.
- HDAC3 activity is NAD+‑sensitive, coupling cellular metabolic state to chromatin state.
- Circadian oscillation of NAD+ levels (driven by NAMPT) thus gates HDAC3 enzymatic output.
- When REV-ERBα expression peaks (subjective night), HDAC3 deacetylates H3K27ac at the MLH1 promoter, maintaining an open, transcription‑permissive state.
- Loss of this rhythm (e.g., via shift‑like lighting or Bmal1 KO) yields sustained acetylation, recruitment of DNMT3A, and promoter methylation that silences MLH1.
Testable Predictions
- Chromatin immunoprecipitation‑sequencing (ChIP‑seq) for REV-ERBα and HDAC3 in mouse colonic crypts will show anti‑phase peaks at the MLH1 promoter that coincide with low H3K27ac and high MLH1 mRNA.
- Pharmacological inhibition of HDAC3 (e.g., with RGFP966) or genetic knockdown of Rev-erbα will increase MLH1 promoter acetylation, reduce MLH1 transcription, and lower MMR activity measured by a fluorescent reporter assay.
- Restoring NAD+ levels with NR supplementation in aged mice will rescue HDAC3 activity, decrease MLH1 promoter methylation, and improve MMR efficiency despite low Rev-erbα expression.
- Human colon biopsies from early‑onset CRC patients with reported circadian disruption will display elevated MLH1 promoter acetylation and methylation relative to age‑matched controls.
Potential Challenges and Controls
- Off‑target effects of HDAC3 inhibitors: use catalytic‑dead HDAC3 rescue experiments.
- Circadian confounding: perform experiments under constant darkness to isolate cell‑autonomous rhythms.
- Microbiome influence: include germ‑free or antibiotic‑treated cohorts to verify that the effect is intrinsic to epithelial clock.
By positioning the circadian repressor REV-ERBα as a rhythmic gatekeeper of HDAC3‑mediated promoter epigenetics, this hypothesis directly connects the erosion of the circadian firewall to the age‑dependent loss of mismatch repair, offering a clear, falsifiable path forward.
Community Sentiment
💡 Do you believe this is a valuable topic?
🧪 Do you believe the scientific approach is sound?
21h 28m remaining
Sign in to vote
Sign in to comment.
Comments